Clinical Trials

Serum tailor-made from patients&8217; immune cells looks safe, researchers say

Agency is 'more cautious' in wake of Vioxx problems, expert says

The makers of the oral contraceptive drospirenone/ethinyl (YAZ) will be marketing their drug as a treatment for moderate acne in women

Genzyme's sevelamer carbonate (Renvela) successfully and significantly reduced serum phosphorus for hyperphosphalemic patients who have chronic kidney disease

Voyager Pharmaceutical Corp recently informed its shareholders of preliminary results from a trial of an investigational drug to treat Alzheimer's disease (AD).

A once-daily, 750-mg dose of levofloxacin (Levaquin) taken for 5 days has been shown to be as effective as a 10-day, 400- to 500-mg regimen of ciprofloxacin for the treatment of complicated urinary tract infections

An investigational drug from Glaxo-SmithKline that is a combination diphtheria/tetanus/inactive poliovirus (DTaPIPV) vaccine demonstrated a good immune response

In a multinational, placebo-controlled trial, rosuvastatin proved to be well-tolerated in patients with dyslipidemia

Targeted Genetics notified FDA earlier that a patient in its trial experienced a serious adverse event.

The approval is opposed by at least two women's groups and FDA scientists question whether the benefits of the drug, called Evista, outweigh its risks...